Accreditation
Accreditation

Prof. Deuschl

Prof. Deuschl

Contact details

Deuschl, Günther, Prof. Dr. Dr. h.c.
Senior-Professor of Neurology
Christian-Albrechts-Universität zu Kiel
Neurology
Schittenhelmstrasse 10
24105 Kiel, Germany

Biography

Education

  • 1970-1974 Ludwig-Maximilians-University Munich: Mathematics, Philosophy History
  • 1974-1980 Ludwig-Maximilians-University Munich: Medicine
  • 1980 MD-Thesis: Spinal anatomy of the Autonomic Nervous System

Clinical career

  • 1980-1982 Neurology Training at the Departments of Neurology, Technical University of Munich (Prof. A, Struppler)
  • 1982-1986 Neurology Training at the Department of Neurology, University of Freiburg, Germany (Prof. C.H. Lücking)
  • 1988 Habilitation (precondition for academic teaching) for Neurology and Clinical Neurophysiology: Long loop reflexes of hand muscles
  • 1986-1995 Associate Professor, Department of Neurology, University of Freiburg, Germany
  • 1986-1991 Board examinations/teaching certificates for Neurology, Pain therapy, Neurological Intensive Care, Laboratory Medicine in Neurology, Geriatric Neurology. Electromyography, Evoked Potentials and Electroencephalography.
  • 1995- 2016 Head of the Department of Neurology, University of Kiel, Germany

Scientific career

  • 1976-1981 Fellow of the ‚Studienstiftung des Deutschen Volkes‘
  • 1976-1980 Experimental Neurophysiology, Department of Physiology, München University (Prof. M. Illert)
  • 1991-1992 National Institute of Health, National Institute of Neurological Disorders and Stroke, Human Motor Control Section, (Prof. M. Hallett), Bethesda/Maryland, USA.
  • 1994 Professor of Neurology and Clinical Neurophysiology, University of Freiburg
  • 1995-2016 Full professor at the Faculty of Medicine, Christian-Albrechts University, Kiel and Head of the Department of Neurology
  • 2016- Professor Emeritus at the Faculty of Medicine, Christian-Albrechts University, Kiel, PI at the Department of Neurology
  • 2018- First Senior Professor of the Christian-Albrechts University Kiel
  • 2018- Guest ProfessorDepartment of Neurology, Zürich University Hospital

Scientific commitments

  • Since 1998 Editor of Aktuelle Neurologie
  • 2004-2010 Editor of ‘Movement Disorders’
  • Since 2001 Editor of ‚Referenzreihe Neurologie’ Thieme Publishers Neurology Book Series,
  • Since 1999 Spokesperson of the ‘German Competence Net Parkinson’
  • Since 1996 Reviewer of the DFG, BMBF, Wellcome Trust, European, Australian and Asian national research funds.
  • 1993-1997 Member of the Executive Committee of the German Society for Clinical Neurophysiology
  • 1995-2013 Member of the Senate of the Christian-Albrechts-University
  • 1994-1998 Member of the International Executive Committee of the Movement Disorder Society.
  • 1997-2001 Member-at-large of the International Federation of Societies for Clinical Neurophysiology
  • 2006-2008 President of the German Society of Neurology
  • 2011-2013 President of the Movement Disorder Society
  • 2014-2018 President of the European Academy of Neurology

Honors

  • 1986 Kornmüller-Award German Society for Clinical Neurophysiology
  • 1994 Parkinson-Award of the German Neurological Society
  • 2001- Member of the Academie Royale de Medicine de Belgique
  • 2000- Visiting Professor Zhejang- University Hangzhou/China
  • 2004 Dingebauer Parkinson Award of the German Neurological Society
  • 2012 Max-Nonne Gedenkmünze of the German Neurological Society
    Honorary member of the Austrian Parkinson Society
  • 2013 2014- Berger Award of the German Society for Clinical Neurophysiology
    Visiting Professor, Shanghai Jiao Tong University School of Medicine
  • 2015 Wilhelm Griesinger Award, Berlin
  • 2015 Doctor honoris causa of the Academy of Sciences of Moldova
  • 2015 Honorary member of the Societe Francaise de Neurologie
  • 2016 Gheorghe Marinescu Medal and Honorary Membership of the Romanian Society for Neurology
  • 2016 Honorary member of the Movement Disorder Society
  • 2018 Wilhelm Erb award of the German Society of Neurology

Major grants

  • 2002- 2006 Neuroimage Nord BMBF
  • 1999- 2009 Kompetenznetz Parkinson
  • 2002- 2009 DFG- 3 Tesla Kernspintomogramm für Neuroimage Nord
  • 2004- 2011 DFG- Popgen Parkinson
  • 2003- 2006 DFG- Training bei Schreibkrampf
  • 2005- 2012 DFG/BMBF Förderprogramm: Clinical study program - Earlystim Studie
  • 2012-2018 Earlystim follow-up Studie
  • 2010-2013 SFB 855, TP D2, deputy speaker
  • 2016-2020 SFB 1261, TP B5, deputy speaker

Shortened list of lifetime achievements 

  • Contributing to the development of Botulinumtoxin therapy
  • Defining the first classification of tremors
  • Developing clinical and electrophysiologic tools for the differential diagnosis of tremors
  • Developing deep brain stimulation as an evidence-based treatment for Parkinson’s disease
  • Explaining the physiology of many effects of DBS on the motor system, the autonomic system, cognition and emotion
  • Building up a clinical research center for tremor and deep brain stimulation at Kiel University
  • Developing the Journal Movement Disorders as one of the third generation editors
  • Developing the Movement Disorder Society as member, Journal Editor and President
  • Developing Neurology in Germany and Europe as President of the respective Societies

Important publications

  • Citation indexes (Google Scholar) (2018)
    Publication list see: https://scholar.google.de/cita...Quotations : >46.000; h-index :
    108; Pubmed-listed papers: >600
  • Deuschl, G., P. Bain, M. Brin, and Ad Hoc Scientific Committee. "Consensus Statement of the Movement Disorder Society on Tremor." Mov Disord 13, no. Suppl 3 (1998): 2-23.
  • Deuschl G,Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, Daniels C, Deutschlander A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-908
  • Kupsch A, Benecke R, Muller J, Trottenberg T, Schneider GH, Poewe W, Eisner W, Wolters A, Muller JU, Deuschl G, Pinsker MO, Skogseid IM, Roeste GK, Vollmer-Haase J, Brentrup A, Krause M, Tronnier V, Schnitzler A, Voges J, Nikkhah G, Vesper J, Naumann M, Volkmann J. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006; 355: 1978-90.
  • Witt, K., C. Daniels, J. Reiff, P. Krack, J. Volkmann, M.O. Pinsker, M. Krause, V. Tronnier, M. Kloss, A. Schnitzler, L. Wojtecki, K. Botzel, A. Danek, R. Hilker, V. Sturm, A. Kupsch, E. Karner, G. Deuschl, Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol, 2008. 7(7): p. 605-14.
  • Bartsch T, Schonfeld R, Muller FJ, Alfke K, Leplow B, Aldenhoff J, Deuschl G, Koch JM. Focal lesions of human hippocampal CA1 neurons in transient global amnesia impair place memory. Science 2010; 328: 1412-5.
  • Bartsch T, Deuschl G.Transient global amnesia: functional anatomy and clinical implications. Lancet Neurol 2010; 9: 205-214.
  • Schuepbach, W. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Halbig, T. D., Hesekamp, H., Navarro, S. M., Meier, N., Falk, D., Mehdorn, M., Paschen, S., Maarouf, M., Barbe, M. T., Fink, G. R., Kupsch, A., Gruber, D., Schneider, G. H., Seigneuret, E., Kistner, A., Chaynes, P., Ory-Magne, F., Brefel Courbon, C., Vesper, J., Schnitzler, A., Wojtecki, L., Houeto, J. L., Bataille, B., Maltete, D., Damier, P., Raoul, S., Sixel-Doering, F., Hellwig, D., Gharabaghi, A., Kruger, R., Pinsker, M. O., Amtage, F., Regis, J. M., Witjas, T., Thobois, S., Mertens, P., Kloss, M., Hartmann, A., Oertel, W. H., Post, B., Speelman, H., Agid, Y., Schade-Brittinger, C., and Deuschl, G.(2013) Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 368, 610-622
  • Deuschl, G.,and Agid, Y. (2013) Subthalamic neurostimulation for Parkinson's disease with early fluctuations: balancing the risks and benefits. Lancet Neurol 12, 1025-1034
  • Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G.MDS research criteria for prodromal Parkinson's disease. Mov Disord. 2015 Oct;30(12):1600-11.
  • Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, Raethjen J, Stamelou M, Testa CM, Deuschl G,Tremor Task Force of the International P, Movement Disorder S. Consensus Statement on the classification of tremors. Mov Disord. 2018Jan;33(1):75-87.
  • Pasquini J, Ceravolo R, Qamhawi Z, Lee JY, Deuschl G, Brooks DJ, Bonuccelli U, Pavese N. Progression of tremor in early stages of Parkinson's disease: a clinical and neuroimaging study. Brain 2018.
  • Muthuraman M, Raethjen J, Koirala N, Anwar AR, Mideksa KG, Elble R, Groppa S, Deuschl G. Cerebello-cortical network fingerprints differ between essential, Parkinson's and mimicked tremors. Brain 2018;141(6):1770-1781.
  • L’hommee E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Halbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Doring F, Kupsch A, Kruger R, Elben S, Chabardes S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltete D, Sauvaget A, Rau J, Schnitzler A, Schupbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P, group Es. Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial. Lancet Neurol 2018;17(3):223-231.
  • Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A. Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol 2018;17(9):749-759.